Coya Therapeutics Announces Conference Call to Report Results from an Investigator-Initiated Phase 2 Trial of Low-Dose Interleukin-2 in Patients with Mild to Moderate Alzheimers Disease
COYA Stock | 6.08 0.19 3.23% |
About 55% of Coya Therapeutics,'s investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Coya Therapeutics, Common suggests that some traders are interested. The current market sentiment, together with Coya Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Coya Therapeutics, Common stock news signals to limit their universe of possible portfolio assets.
Coya |
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologics intended to enhance regu
Read at businesswire.com
![]() |
Coya Therapeutics, Fundamental Analysis
We analyze Coya Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coya Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coya Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Coya Therapeutics, is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Coya Therapeutics, Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics, stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics, could also be used in its relative valuation, which is a method of valuing Coya Therapeutics, by comparing valuation metrics with similar companies.
Peers
Coya Therapeutics, Related Equities
CUE | Cue Biopharma | 6.62 | ||||
INAB | In8bio | 4.00 | ||||
DRMA | Dermata Therapeutics | 1.65 | ||||
LTRN | Lantern Pharma | 1.23 | ||||
CNTA | Centessa Pharmaceuticals | 0.29 | ||||
NAMSW | NewAmsterdam Pharma | 0.44 | ||||
HLVX | Hillevax | 0.50 | ||||
FENC | Fennec Pharmaceuticals | 0.91 | ||||
TCRX | Tscan Therapeutics | 1.15 | ||||
STRO | Sutro Biopharma | 1.54 | ||||
OPT | Opthea | 2.11 | ||||
GANX | Gain Therapeutics | 2.74 | ||||
INZY | Inozyme Pharma | 3.36 | ||||
TERN | Terns Pharmaceuticals | 3.88 | ||||
DAWN | Day One | 3.96 | ||||
ABOS | Acumen Pharmaceuticals | 5.66 | ||||
CGTX | Cognition Therapeutics | 8.86 |
Complementary Tools for Coya Stock analysis
When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |